1 – 10 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential
2021) In Oncogene(
- Contribution to journal › Scientific review
- 2020
-
Mark
FRMD6 has tumor suppressor functions in prostate cancer
2020) In Oncogene(
- Contribution to journal › Article
- 2019
-
Mark
The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
(
- Contribution to journal › Article
-
Mark
Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
(
- Contribution to journal › Article
- 2016
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
(
- Contribution to journal › Article
-
Mark
Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
(
- Contribution to journal › Article
-
Mark
Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism.
2015) In Oncogene(
- Contribution to journal › Article
-
Mark
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
(
- Contribution to journal › Article